We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current DYMDF market cap is 156.75M. The company's latest EPS is SEK -1.2588 and P/E is -1.35.
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 1.64M | 44.3M | 444k | 2.59M | 3.75M |
| Operating Income | -36.57M | 9.74M | -85.88M | -118.18M | -120.81M |
| Net Income | -36.61M | 9.71M | 60.05M | -103.52M | -116.07M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 74.2M | 89.76M | 201.44M | 236.52M | 205.81M |
| Total Liabilities | 11.42M | 17.28M | 12.18M | 22.15M | 36.41M |
| Total Equity | 62.78M | 72.49M | 189.26M | 214.38M | 169.4M |
| Year End 31 August 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -39.19M | 16.88M | -109.47M | -93.22M | -110.96M |
| Investing | 5.35M | 4.82M | 132.53M | -76.72M | 28.4M |
| Financing | 56.38M | N/A | 56.72M | 142.16M | 86.54M |
| Market Cap | 156.75M |
| Price to Earnings Ratio | -1.35 |
| Price to Sales Ratio | 41.87 |
| Price to Cash Ratio | 1.23 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 92.21M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Diamyd Med AB (GM) |
| Address |
kungsgatan 29 stockholm SE-111 56 |
| Website | https://www.diamyd.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
